Angstrom Biotech Profile
Key Indicators
- Authorised Capital ₹ 2.50 M
- Paid Up Capital ₹ 1.49 M
- Company Age 25 Year, 9 Days
- Last Filing with ROC 31 Mar 2022
- Open Charges ₹ 20.00 Cr
- Satisfied Charges ₹ 2.70 M
- Revenue Growth -2.43%
- Profit Growth -59.55%
- Ebitda -53.91%
- Net Worth 43.62%
- Total Assets 26.38%
About Angstrom Biotech
Angstrom Biotech Private Limited (ABPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 24 January 2000 and has a history of 25 years. Its registered office is in Vadodara, Gujarat, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2022. It's a company limited by shares with an authorized capital of Rs 2.50 M and a paid-up capital of Rs 1.49 M.
The company currently has active open charges totaling ₹20.00 Cr. The company has closed loans amounting to ₹2.70 M, as per Ministry of Corporate Affairs (MCA) records.
Company Details
-
Location
Vadodara, Gujarat, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media
Corporate Identity Details
-
CIN/LLPIN
U24119GJ2000PTC037233
-
Company No.
037233
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
24 Jan 2000
-
Date of AGM
30 Sep 2022
-
Date of Balance Sheet
31 Mar 2022
-
Listing Status
Unlisted
-
ROC Code
Roc Ahmedabad
Industry
What products or services does Angstrom Biotech Private Limited offer?
Angstrom Biotech Private Limited offers a wide range of products and services, including Testing & Measuring Equipments, Test Kits, Urological & Obstetrics Instruments, Urinary Catheter, Medical Laboratory Instruments, Rapid Test Kit, Corona Test Kit, Surgical Instruments & Accessories, Surgical Accessories, Infusion Syringes & Supplies.
Who are the key members and board of directors at Angstrom Biotech?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rahul Yadav
|
Director | 14-Mar-2016 | Current |
|
Sunita Yadav
|
Director | 14-Mar-2016 | Current |
Financial Performance of Angstrom Biotech.
Angstrom Biotech Private Limited, for the financial year ended 2022, experienced Minor drop in revenue, with a 2.43% decrease. The company also saw a substantial fall in profitability, with a 59.55% decrease in profit. The company's net worth Soared by an impressive increase of 43.62%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Angstrom Biotech?
In 2022, Angstrom Biotech had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Cardiomac India Private LimitedRahul Yadav and Sunita Yadav are mutual person
-
Innovation Triggers Mgmt Private LimitedRahul Yadav and Sunita Yadav are mutual person
Charges (Loans)
₹200.00 M
₹2.70 M
Charges Breakdown by Lending Institutions
- Hdfc Bank Limited : 20.00 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 04 Feb 2022 | Hdfc Bank Limited | ₹20.00 Cr | Open |
| 31 Aug 2001 | Gujarat State Financial Corporation | ₹2.70 M | Satisfied |
How Many Employees Work at Angstrom Biotech?
Angstrom Biotech has a workforce of 1 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Angstrom Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Angstrom Biotech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
_PRIVATE_LIMITED.webp){kind=small}
